Mercy Family Medicine Residency Mason City, IA - 50401

Mercy Family Medicine Residency is categorized under Family Practice Doctors in Mason City, IA and active since 2000.

Mercy Family Medicine Residency was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.

If you are seeking more information, feel free to contact Chad Mcchamderidge at the company’s single location by writing to 101 South Theater, Mason City, Iowa IA 50401 or by phoning (641) 428-7766. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mercy Family Medicine Residency
Contact Person: Chad Mcchamderidge
Address: 101 South Theater, Mason City, Iowa 50401
Phone Number: (641) 428-7766
Annual Revenue (USD): $100.000 to $499.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:

Mercy Family Medicine Residency was started in 2000 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Chad Mcchamderidge for inquiries that concern Mercy Family Medicine Residency by calling the company number (641) 428-7766, as your correspondence is most welcome. Additionally, the physical location of the single location of Mercy Family Medicine Residency can be found at the coordinates 43.15448,-93.19366 as well as the street address 101 South Theater in Mason City, Iowa 50401.

For its online presence, you may visit Mercy Family Medicine Residency’s website at and engage with its social media outlets through on Twitter and on Facebook.